# Aprena-scRNAseq-analysis

Single-cell RNA sequencing analysis associated with the manuscript: T Kruer et al. "XPO1 Over-expression Drives Resistance to Eprenetapopt and Azacitidine and can be Therapeutically Exploited in TP53 Mutated Myeloid Malignancies" presented at [ASH2022](https://ashpublications.org/blood/article/140/Supplement%201/99/490003/XPO1-Overexpression-Is-a-Mechanism-of-Resistance). 
